BusinessARCA biopharma Announces GENETIC-AF Data and Safety Monitoring Board Recommendation to Complete Phase 2B GENETIC-AF Clinical Trial Based on Efficacy and Safety Data in Phase 2B Interim AnalysisBy Nasdaq OMXAug 9, 2017, 8:30 PM UTC
BusinessARCA Biopharma Announces Database Lock for GENETIC-AF Phase 2B Interim Efficacy Analysis – DSMB Recommendation Anticipated in August 2017By Nasdaq OMXJun 20, 2017, 12:30 PM UTC
BusinessARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMay 15, 2017, 12:32 PM UTC
BusinessARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMay 15, 2017, 12:32 PM UTC
BusinessARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMay 15, 2017, 12:32 PM UTC
